These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11680650)

  • 41. Mucosal immunity and tolerance in the elderly.
    Fujihashi K; McGhee JR
    Mech Ageing Dev; 2004 Dec; 125(12):889-98. PubMed ID: 15563935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse and Human Liver Contain Immunoglobulin A-Secreting Cells Originating From Peyer's Patches and Directed Against Intestinal Antigens.
    Moro-Sibilot L; Blanc P; Taillardet M; Bardel E; Couillault C; Boschetti G; Traverse-Glehen A; Defrance T; Kaiserlian D; Dubois B
    Gastroenterology; 2016 Aug; 151(2):311-23. PubMed ID: 27132185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin.
    Lycke N; Holmgren J
    Scand J Immunol; 1986 May; 23(5):611-6. PubMed ID: 3704560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues.
    Csencsits KL; Pascual DW
    J Immunol; 2002 Nov; 169(10):5649-59. PubMed ID: 12421944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
    Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
    J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral tolerance.
    Garside P; Mowat AM
    Semin Immunol; 2001 Jun; 13(3):177-85. PubMed ID: 11394960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
    Hashizume-Takizawa T; Yamamoto M
    Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
    Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
    Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
    J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kefir milk enhances intestinal immunity in young but not old rats.
    Thoreux K; Schmucker DL
    J Nutr; 2001 Mar; 131(3):807-12. PubMed ID: 11238763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep.
    Mutwiri G; Watts T; Lew L; Beskorwayne T; Papp Z; Baca-Estrada ME; Griebel P
    Immunology; 1999 Jul; 97(3):455-61. PubMed ID: 10447767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological functions of the gut--role of the mucosal immune system.
    Nagura H; Sumi Y
    Toxicol Pathol; 1988; 16(2):154-64. PubMed ID: 3055225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice.
    Peng X; Cebra JJ; Adler MW; Meissler JJ; Cowan A; Feng P; Eisenstein TK
    J Immunol; 2001 Oct; 167(7):3677-81. PubMed ID: 11564781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.